Mylene Cayol
Overview
Explore the profile of Mylene Cayol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
192
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benyahia Z, Gaudy-Marqueste C, Berenguer-Daize C, Chabane N, Dussault N, Cayol M, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497391
Introduction: Metastatic melanoma is an aggressive tumor and can constitute a real therapeutic challenge despite the significant progress achieved with targeted therapies and immunotherapies, thus highlighting the need for the...
2.
Sigaud R, Dussault N, Berenguer-Daize C, Vellutini C, Benyahia Z, Cayol M, et al.
Front Oncol
. 2021 Oct;
11:753244.
PMID: 34692535
VE-cadherin is an essential adhesion molecule in endothelial adherens junctions, and the integrity of these complexes is thought to be regulated by VE-cadherin tyrosine phosphorylation. We have previously shown that...
3.
Benyahia Z, Dussault N, Cayol M, Sigaud R, Berenguer-Daize C, Delfino C, et al.
Oncotarget
. 2017 Feb;
8(9):15744-15762.
PMID: 28178651
Tumor- or cancer-associated fibroblasts (TAFs or CAFs) are active players in tumorigenesis and exhibit distinct angiogenic and tumorigenic properties. Adrenomedullin (AM), a multifunctional peptide plays an important role in angiogenesis...
4.
Berenguer-Daize C, Astorgues-Xerri L, Odore E, Cayol M, Cvitkovic E, Noel K, et al.
Int J Cancer
. 2016 Jul;
139(9):2047-55.
PMID: 27388964
Bromodomain and extraterminal (BET) bromodomain (BRD) proteins are epigenetic readers that bind to acetylated lysine residues on chromatin, acting as co-activators or co-repressors of gene expression. BRD2 and BRD4, members...
5.
Greillier L, Tounsi A, Berenguer-Daize C, Dussault N, Delfino C, Benyahia Z, et al.
J Thorac Oncol
. 2016 Jan;
11(1):94-107.
PMID: 26762744
Introduction: Malignant pleural mesothelioma (MPM) grows aggressively within the thoracic cavity and has a very low cure rate, thus highlighting the need for identification of new therapeutic targets. Adrenomedullin (AM)...
6.
Khalfaoui-Bendriss G, Dussault N, Fernandez-Sauze S, Berenguer-Daize C, Sigaud R, Delfino C, et al.
Oncotarget
. 2015 Apr;
6(10):7536-53.
PMID: 25924235
The cellular and molecular mechanisms by which adrenomedullin (AM) blockade suppresses tumor neovessels are not well defined. Herein, we show that AM blockade using anti-AM and anti-AM receptors antibodies targets...
7.
Jiguet-Jiglaire C, Cayol M, Mathieu S, Jeanneau C, Bouvier-Labit C, Ouafik L, et al.
J Biomed Opt
. 2014 Jan;
19(1):16019.
PMID: 24474505
Whole-body imaging of experimental tumor growth is more feasible within the near-infrared (NIR) optical window because of the highest transparency of mammalian tissues within this wavelength spectrum, mainly due to...
8.
Berenguer-Daize C, Boudouresque F, Bastide C, Tounsi A, Benyahia Z, Acunzo J, et al.
Clin Cancer Res
. 2013 Oct;
19(22):6138-50.
PMID: 24100627
Purpose: To study the role of the adrenomedullin system [adrenomedullin and its receptors (AMR), CLR, RAMP2, and RAMP3] in prostate cancer androgen-independent growth. Experimental Design: Androgen-dependent and -independent prostate cancer...